EVLVW vs WST · rev $29.1M vs P/E 35, rev $1.72B
Evolv Technologies Holdings Inc (EVLVW) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Evolv Technologies Holdings Inc (EVLVW) common stock listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported EVLVW revenue for 2024-12-31 was $29.1M. Net income was -$15.7M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. EVLVW currently screens at market cap $0.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
EVLVW currently screens at market cap $0. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the EVLVW and WST stock pages for the full models.
Not investment advice.